LimmaTech Biologics AG   Report issue

For profit Phase 1 Phase 2
Founded: Schlieren Switzerland (2015)

Organization Overview

First Clinical Trial
2015
NCT02388009
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

LimmaTech Biologics AG